Annual Current Assets
$475.63 M
+$94.40 M+24.76%
December 31, 2023
Summary
- As of February 7, 2025, CHRS annual total current assets is $475.63 million, with the most recent change of +$94.40 million (+24.76%) on December 31, 2023.
- During the last 3 years, CHRS annual current assets has fallen by -$291.85 million (-38.03%).
- CHRS annual current assets is now -38.03% below its all-time high of $767.48 million, reached on December 31, 2020.
Performance
CHRS Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$369.02 M
-$188.91 M-33.86%
September 30, 2024
Summary
- As of February 7, 2025, CHRS quarterly total current assets is $369.02 million, with the most recent change of -$188.91 million (-33.86%) on September 30, 2024.
- Over the past year, CHRS quarterly current assets has dropped by -$75.34 million (-16.95%).
- CHRS quarterly current assets is now -51.92% below its all-time high of $767.48 million, reached on December 31, 2020.
Performance
CHRS Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
CHRS Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +24.8% | -16.9% |
3 y3 years | -38.0% | -4.3% |
5 y5 years | +463.3% | -4.3% |
CHRS Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -21.0% | +24.8% | -41.2% | +16.8% |
5 y | 5-year | -38.0% | +38.7% | -51.9% | +16.8% |
alltime | all time | -38.0% | +1817.9% | -51.9% | +707.9% |
Coherus BioSciences Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $369.02 M(-33.9%) |
Jun 2024 | - | $557.93 M(-11.1%) |
Mar 2024 | - | $627.48 M(+31.9%) |
Dec 2023 | $153.97 M(+54.6%) | $475.63 M(+7.0%) |
Sep 2023 | - | $444.37 M(+15.3%) |
Jun 2023 | - | $385.48 M(+22.0%) |
Mar 2023 | - | $315.93 M(-17.1%) |
Dec 2022 | $99.61 M(+29.3%) | $381.23 M(-15.0%) |
Sep 2022 | - | $448.27 M(+0.3%) |
Jun 2022 | - | $446.78 M(-12.8%) |
Mar 2022 | - | $512.44 M(-14.9%) |
Dec 2021 | $77.01 M(+3.8%) | $602.32 M(-10.5%) |
Sep 2021 | - | $673.04 M(+2.0%) |
Jun 2021 | - | $660.01 M(+6.9%) |
Mar 2021 | - | $617.26 M(-19.6%) |
Dec 2020 | $74.17 M(+12.5%) | $767.48 M(+5.6%) |
Sep 2020 | - | $726.92 M(+7.6%) |
Jun 2020 | - | $675.86 M(+71.0%) |
Mar 2020 | - | $395.18 M(+15.2%) |
Dec 2019 | $65.92 M | $343.01 M(+24.1%) |
Sep 2019 | - | $276.38 M(+34.4%) |
Jun 2019 | - | $205.63 M(+29.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $159.16 M(+88.5%) |
Dec 2018 | $15.03 M(-12.3%) | $84.43 M(-35.2%) |
Sep 2018 | - | $130.31 M(-24.6%) |
Jun 2018 | - | $172.78 M(+53.9%) |
Mar 2018 | - | $112.24 M(-22.8%) |
Dec 2017 | $17.13 M(+0.8%) | $145.48 M(-15.2%) |
Sep 2017 | - | $171.60 M(+11.9%) |
Jun 2017 | - | $153.34 M(-26.4%) |
Mar 2017 | - | $208.26 M(+29.0%) |
Dec 2016 | $17.00 M(+13.3%) | $161.49 M(-8.9%) |
Sep 2016 | - | $177.32 M(-25.1%) |
Jun 2016 | - | $236.83 M(+11.9%) |
Mar 2016 | - | $211.58 M(+7.2%) |
Dec 2015 | $15.00 M(+85.5%) | $197.39 M(+4.3%) |
Sep 2015 | - | $189.30 M(-21.0%) |
Jun 2015 | - | $239.59 M(+66.5%) |
Mar 2015 | - | $143.90 M(-19.7%) |
Dec 2014 | $8.09 M(+356.8%) | $179.14 M(+50.7%) |
Sep 2014 | - | $118.88 M(+3.6%) |
Jun 2014 | - | $114.71 M(+151.1%) |
Dec 2013 | $1.77 M(+2.1%) | $45.68 M |
Dec 2012 | $1.73 M | - |
FAQ
- What is Coherus BioSciences annual total current assets?
- What is the all time high annual current assets for Coherus BioSciences?
- What is Coherus BioSciences annual current assets year-on-year change?
- What is Coherus BioSciences quarterly total current assets?
- What is the all time high quarterly current assets for Coherus BioSciences?
- What is Coherus BioSciences quarterly current assets year-on-year change?
What is Coherus BioSciences annual total current assets?
The current annual current assets of CHRS is $475.63 M
What is the all time high annual current assets for Coherus BioSciences?
Coherus BioSciences all-time high annual total current assets is $767.48 M
What is Coherus BioSciences annual current assets year-on-year change?
Over the past year, CHRS annual total current assets has changed by +$94.40 M (+24.76%)
What is Coherus BioSciences quarterly total current assets?
The current quarterly current assets of CHRS is $369.02 M
What is the all time high quarterly current assets for Coherus BioSciences?
Coherus BioSciences all-time high quarterly total current assets is $767.48 M
What is Coherus BioSciences quarterly current assets year-on-year change?
Over the past year, CHRS quarterly total current assets has changed by -$75.34 M (-16.95%)